Korean J Dermatol.  2009 Mar;47(3):338-342.

A Case of Primary Cutaneous CD4+ Small/Medium-sized Pleomorphic T-cell Lymphoma

Affiliations
  • 1Department of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Abstract

Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma (CSMTCL) is a rare disease constituting 2% of all cutaneous T-cell lymphomas. In most cases, CSMTCL occurs as a solitary lesion and has an indolent course. Here we present a 42-year-old woman with multiple, localized, recurrent, erythematous papules and macules that developed after combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP).

Keyword

CD4; CHOP chemotherapy; Lymphoma; Pleomorphic; Small/medium-sized

MeSH Terms

Adult
Cyclophosphamide
Doxorubicin
Drug Therapy, Combination
Female
Humans
Lymphoma
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Prednisolone
Rare Diseases
T-Lymphocytes
Vincristine
Cyclophosphamide
Doxorubicin
Prednisolone
Vincristine
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr